Published in Vaccine Weekly, July 20th, 2005
Under a new lease agreement with Greer, AlphaVax has assumed direct responsibility for vaccine manufacturing operations using Greer's vaccine production facility in Lenoir, including employment of several Greer staff who are involved in making AlphaVax vaccines there. Previously, vaccines that the company makes for use in clinical trials were produced at Greer under a contract manufacturing arrangement put in place in 2000.
In announcing the change, Andrew Graham, VP of Development at AlphaVax and the executive responsible for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly